FIRST TRUST ADVISORS LP - ACCELERON PHARMA INC ownership

ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 339 filers reported holding ACCELERON PHARMA INC in Q3 2021. The put-call ratio across all filers is 0.38 and the average weighting 0.5%.

Quarter-by-quarter ownership
FIRST TRUST ADVISORS LP ownership history of ACCELERON PHARMA INC
ValueSharesWeighting
Q3 2021$1,102,000
-89.5%
6,405
-92.3%
0.00%
-90.9%
Q2 2021$10,467,000
-50.8%
83,412
-46.8%
0.01%
-57.7%
Q1 2021$21,258,000
-6.3%
156,761
-11.6%
0.03%
-13.3%
Q4 2020$22,684,000
+5.0%
177,304
-7.7%
0.03%
-14.3%
Q3 2020$21,611,000
+452.4%
192,043
+367.7%
0.04%
+400.0%
Q2 2020$3,912,000
-0.5%
41,061
-6.1%
0.01%
-22.2%
Q1 2020$3,931,000
+816.3%
43,736
+440.9%
0.01%
+800.0%
Q4 2019$429,000
-43.3%
8,086
-50.2%
0.00%
-50.0%
Q1 2019$756,000
-48.5%
16,238
-51.8%
0.00%
-33.3%
Q4 2018$1,467,000
-43.2%
33,683
-25.4%
0.00%
-40.0%
Q3 2018$2,583,000
+104.2%
45,128
+39.5%
0.01%
+66.7%
Q1 2018$1,265,000
+96.4%
32,354
+113.2%
0.00%
+50.0%
Q4 2017$644,000
-47.7%
15,178
-68.5%
0.00%
-50.0%
Q4 2016$1,231,000
+7.9%
48,251
+53.0%
0.00%
+33.3%
Q3 2016$1,141,00031,5330.00%
Other shareholders
ACCELERON PHARMA INC shareholders Q3 2021
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 1,449,300$59,537,000,0006.61%
Foresite Capital Management II, LLC 188,602$7,748,0004.36%
Foresite Capital Management III, LLC 254,923$10,472,0003.43%
Artal Group S.A. 1,500,000$61,620,0002.49%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,305,174$53,617,0001.93%
Asymmetry Capital Management, L.P. 82,473$3,388,0001.84%
QVT Financial LP 190,977$7,845,0001.66%
SECTORAL ASSET MANAGEMENT INC 269,396$11,067,0001.32%
Sofinnova Investments, Inc. 241,043$9,902,0000.91%
Novo Holdings A/S 119,708$4,918,0000.69%
View complete list of ACCELERON PHARMA INC shareholders